ZFYVE26
protein-codingzinc finger FYVE-type containing 26, the group of Zinc fingers FYVE-type
Gene summary
This gene encodes a protein which contains a FYVE zinc finger binding domain. The presence of this domain is thought to target these proteins to membrane lipids through interaction with phospholipids in the membrane. Mutations in this gene are associated with autosomal recessive spastic paraplegia-15. [provided by RefSeq, Oct 2008]
- SPG15
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~89.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0010044
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0010044
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0010044
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0010044
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0010044
Submitter: Myriad Women's Health
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ZFYVE26 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_015346.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 15 | 990 | 14 | 1021 | |
| missense | 2 | 14 | 784 | 46 | 8 | 854 |
| nonsense | 82 | 62 | 4 | 148 | ||
| start loss | 1 | 1 | ||||
| frameshift | 91 | 91 | 2 | 184 | ||
| splice donor/acceptor (+/-2bp) | 7 | 70 | 7 | 84 | ||
| Total | 183 | 239 | 812 | 1036 | 22 | 2292 |
Highest pathogenic variant AF is 0.00008735962
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_056161.2 | 41 | MANE Select | |
| Ensembl | ENSP00000251119.5 | 41 | MANE Select | |
| Ensembl | ENSP00000450431.1 | 8 | Standard | |
| Ensembl | ENSP00000450603.1 | 34 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| zfyve26 | Danio rerio | Structure: motor neuron Quality: branchiness abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- mitotic cytokinesis
- double-strand break repair via homologous recombination
- regulation of cytokinesis
Molecular Function
- protein binding
- phosphatidylinositol-3-phosphate binding
- metal ion binding
Cellular Component
- lysosomal membrane
- centrosome
- midbody
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000347230
- Coding exons
- 41
- Length
- 89217
- Individuals with no LoFs
- 125614
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 134
- Defined
- 125748
- p
- 0.000533
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.520 | 1280 | 1.33e+3 | 0.960 | 0.0000775 | 16499 |
| Missense (PolyPhen) | 314 | 382.62 | 0.82065 | 5122 | ||
| Synonymous | 0.511 | 521 | 536 | 0.972 | 0.0000301 | 5150 |
| Loss of Function | 5.23 | 58 | 120 | 0.484 | 0.00000624 | 1427 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00043 | 0.00043 | rare |
| Latino/Admixed American | 0.00038 | 0.00038 | rare |
| Ashkenazi Jewish | 0.00030 | 0.00030 | rare |
| East Asian | 0.00043 | 0.00044 | rare |
| Finnish | 0.00028 | 0.00028 | rare |
| European (Non-Finnish) | 0.00069 | 0.00069 | rare |
| South Asian | 0.00059 | 0.00059 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Phosphatidylinositol 3-phosphate-binding protein required for the abcission step in cytokinesis: recruited to the midbody during cytokinesis and acts as a regulator of abcission. May also be required for efficient homologous recombination DNA double-strand break repair. {ECO:0000269|PubMed:20208530}.;
- Disease
- DISEASE: Spastic paraplegia 15, autosomal recessive (SPG15) [MIM:270700]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG15 is a complex form associated with additional neurological symptoms such as cognitive deterioration or mental retardation, axonal neuropathy, mild cerebellar signs, and, less frequently, a central hearing deficit, decreased visual acuity, or retinal degeneration. {ECO:0000269|PubMed:18394578, ECO:0000269|PubMed:19084844, ECO:0000269|PubMed:19805727}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- LoFtool
- 0.892
- RVIS EVS
- -0.27
- RVIS percentile EVS
- 33.59
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.397
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |